Search
Powered By HealthLine
Special Offers
Health Tools
 Cold & Flu Remedies
 Symptoms Checker
 Quiz: Cold & Flu Myths
 Flu Vaccine Guide
 Avian Flu Guide
Featured Conditions
 Cold & Flu
 Allergy
 Diet & Exercise
 Depression
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Many Hospitalized With Swine Flu Had Been Healthy


Related Encyclopedia
 border=
Abscess
Acne
Actinomycosis
Acute Myeloid Leukemia (Adult)
More...

Related Healthscout Videos
 border=
Sports: Play Younger, Play Longer
Fixing Babies' Heads
Removing Tumors Through the Nose
Attacking Implant Infections
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Dental Cavities
Erectile Dysfunction
More...

Related Drug Information
 border=
Abilify
Actonel
Adderal XR
Augmentin
More...

Related News Articles
 border=
Absent Father Might Mean Earlier Puberty for Higher-Income Girls
Antibiotics for Viral Respiratory Infections in Hospital Decried
Lack of Sleep During Pregnancy Ups Risk of High Blood Pressure
Most Suicidal Teens Seen in ER Receive Follow-up Care
More...


Page:  << Prev | 1 | 2

Schuchat said Tuesday that 9.8 million doses of the H1N1 vaccine are available. "I am happy to say that about half of the vaccine that's available for order is now the injectable form," she said.

The first batches of the vaccine were in a nasal spray called FluMist. Because FluMist is a live vaccine, it's only recommended for healthy people between the ages of 2 to 49 years old, and not for pregnant women, Schuchat said.

Schuchat said the availability of the H1N1 vaccine will continue to grow and ample supplies should be on hand by the end of October and early November. The CDC has been saying for some time that it anticipates having 40 million doses by the end of October and 190 million doses by year's end.

Text Continues Below



"Pregnancy and underlying conditions are ones that we highlight as recommended to receive the H1N1 vaccine when it becomes available in communities," she said.

Asked why pregnancy seemed to be a risk factor for complications from the H1N1 swine flu, Schuchat said: "There are probably two factors that influence the risk that pregnant women have for influenza complication. And this applies to both seasonal flu and the H1N1 flu. In pregnancy, there's a change in the immune system which makes it easier for the woman to hold the fetus and not have an immune reaction to the baby. And so risk of infections can be greater.

"The second issue," she added, "is probably more mechanical, that as the woman gets larger with the baby growing, there can be pressing on the airways and really a restrictive lung disease. So it's harder to take a deep breath and it's harder to fight off a lung infection especially in the later stages of pregnancy."

As for the regular seasonal flu, Schuchat said 77 million doses of that vaccine have been shipped. Although some parts of the country are seeing shortages of the vaccine, those shortfalls are expected to be temporary, with large quantities of the vaccine available in late October and November.

Since the seasonal flu season hasn't started yet, there's plenty of time to get a seasonal flu shot, even into December, Schuchat said.

More information

For more on the H1N1 flu, visit the U.S. Centers for Disease Control and Prevention.

Page:  << Prev | 1 | 2

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 10/13/2009

Related Links
 border=
From Healthscout's partner site on allergy, MyAllergyNetwork.com
QUIZ: Test your knowledge of allergy causes and treatments
DRUGS: Common drugs used to treat allergies
SYMPTOMS: Images and information on allergy symptoms





SOURCES: Oct. 13, 2009, teleconference with Anne Schuchat, M.D., director, National Center for Immunization and Respiratory Diseases, U.S. Centers for Disease Control and Prevention


HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2010. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy